Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 5 studies | 24% ± 7% | |
astrocyte | 4 studies | 26% ± 6% | |
epithelial cell | 3 studies | 20% ± 5% | |
GABAergic neuron | 3 studies | 32% ± 4% | |
glutamatergic neuron | 3 studies | 41% ± 7% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 35% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1976.19 | 2637 / 2642 | 100% | 14.34 | 704 / 705 |
prostate | 100% | 1907.67 | 245 / 245 | 99% | 6.98 | 499 / 502 |
thymus | 100% | 2553.83 | 653 / 653 | 99% | 9.48 | 599 / 605 |
breast | 100% | 1660.52 | 459 / 459 | 98% | 8.49 | 1098 / 1118 |
kidney | 100% | 1498.38 | 89 / 89 | 95% | 6.88 | 860 / 901 |
ovary | 100% | 1764.34 | 180 / 180 | 95% | 7.11 | 408 / 430 |
lung | 100% | 1559.50 | 577 / 578 | 95% | 6.21 | 1095 / 1155 |
adrenal gland | 100% | 2113.20 | 258 / 258 | 93% | 7.58 | 215 / 230 |
pancreas | 99% | 950.35 | 326 / 328 | 94% | 5.06 | 167 / 178 |
esophagus | 100% | 1460.79 | 1443 / 1445 | 93% | 5.14 | 170 / 183 |
uterus | 100% | 2010.66 | 170 / 170 | 91% | 5.64 | 419 / 459 |
skin | 99% | 1258.20 | 1796 / 1809 | 90% | 5.93 | 427 / 472 |
bladder | 100% | 1542.57 | 21 / 21 | 83% | 3.96 | 416 / 504 |
stomach | 99% | 1196.78 | 357 / 359 | 80% | 3.27 | 229 / 286 |
intestine | 100% | 1722.01 | 966 / 966 | 76% | 2.91 | 400 / 527 |
liver | 94% | 668.31 | 212 / 226 | 62% | 2.57 | 250 / 406 |
adipose | 100% | 1498.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1530.44 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2155.56 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.24 | 1 / 1 |
blood vessel | 100% | 1595.32 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1709.45 | 856 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 5.77 | 41 / 45 |
lymph node | 0% | 0 | 0 / 0 | 86% | 5.59 | 25 / 29 |
eye | 0% | 0 | 0 / 0 | 70% | 3.66 | 56 / 80 |
peripheral blood | 63% | 765.02 | 586 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZSCAN30 |
Protein name | Zinc finger and SCAN domain containing 30 Zinc finger and SCAN domain-containing protein 30 (ZNF-WYM) (Zinc finger protein 397 opposite strand) (Zinc finger protein 397OS) |
Synonyms | ZNF397OS |
Description | FUNCTION: May be involved in transcriptional regulation. |
Accessions | M0QZP2 ENST00000592211.1 A0A0C4DGV0 ENST00000589178.5 Q86W11 M0R1Y0 K7ERA9 C9JCM2 ENST00000592278.1 ENST00000588448.1 M0QZC3 ENST00000420878.7 [Q86W11-1] ENST00000610712.1 ENST00000333206.10 [Q86W11-1] K7EPB0 ENST00000601405.1 ENST00000592598.1 |